PKA inhibition kills l-asparaginase-resistant leukemic cells from relapsed acute lymphoblastic leukemia patients

Jung Kwon Lee,Xidi Wang,Jinghua Wang,Jesusa L. Rosales,Ki-Young Lee

DOI: https://doi.org/10.1038/s41420-024-02028-w

2024-05-28

Cell Death Discovery

Abstract:Despite the success in treating newly diagnosed pediatric acute lymphoblastic leukemia (aLL), the long-term cure rate for the 20% of children who relapse is poor, making relapsed aLL the primary cause of cancer death in children. By unbiased genome-wide retroviral RNAi screening and knockdown studies, we previously discovered opioid receptor mu 1 (OPRM1) as a new aLL cell resistance biomarker for the aLL chemotherapeutic drug, l -asparaginase, i.e., OPRM1 loss triggers l -asparaginase resistance. Indeed, aLL cell OPRM1 level is inversely proportional to l -asparaginase IC50: the lower the OPRM1 level, the higher the l -asparaginase IC50, indicating that aLL cells expressing reduced OPRM1 levels show resistance to l -asparaginase. In the current study, we utilized OPRM1-expressing and -knockdown aLL cells as well as relapsed patient aLL cells to identify candidate targeted therapy for l -asparaginase-resistant aLL. In OPRM1-expressing cells, l -asparaginase induces apoptosis via a cascade of events that include OPRM1-mediated decline in [cAMP] i , downregulation of PKA-mediated BAD S 118 phosphorylation that can be reversed by 8-CPT-cAMP, cyt C release from the mitochondria, and subsequent caspase activation and PARP1 cleavage. The critical role of PKA inhibition due to a decrease in [cAMP] i in this apoptotic process is evident in the killing of OPRM1-knockdown and low OPRM1-expressing relapsed patient aLL cells by the PKA inhibitors, H89 and 14–22 amide. These findings demonstrate for the first time that PKA can be targeted to kill aLL cells resistant to l -asparaginase due to OPRM1 loss, and that H89 and 14–22 amide may be utilized to destroy l -asparaginase-resistant patient aLL cells.

cell biology

What problem does this paper attempt to address?

This paper aims to solve the problem of L - asparaginase resistance in patients with relapsed acute lymphoblastic leukemia (ALL). Specifically, through genome - wide retroviral RNA interference screening and knockdown experiments, the researchers found that opioid receptor μ1 (OPRM1) is a new biomarker for L - asparaginase resistance. The deletion of OPRM1 will lead to an increase in the resistance of ALL cells to L - asparaginase. The paper further explored how L - asparaginase induces apoptosis in ALL cells through the OPRM1 - mediated pathway and proposed that PKA inhibitors (such as H89 and 14 - 22 amide) can be used as a new strategy for the treatment of L - asparaginase - resistant ALL.

### Main research contents:
1. **The relationship between OPRM1 and L - asparaginase resistance**:
- The study found that the level of OPRM1 in ALL cells is negatively correlated with the half - maximal inhibitory concentration (IC50) of L - asparaginase. That is, the lower the level of OPRM1, the higher the IC50 of L - asparaginase, indicating that ALL cells with a decreased level of OPRM1 have an increased resistance to L - asparaginase.

2. **The apoptosis - inducing mechanism of L - asparaginase**:
- L - asparaginase causes a decrease in cAMP levels in ALL cells through the OPRM1 - mediated pathway, which in turn affects PKA - mediated BAD S118 phosphorylation. This will lead to an increase in the permeability of the outer mitochondrial membrane, the release of cytochrome C, and finally the activation of caspase and PARP1, causing cell apoptosis.

3. **The role of PKA inhibitors**:
- The study found that PKA inhibitors H89 and 14 - 22 amide can kill L - asparaginase - resistant ALL cells with OPRM1 deletion or low expression levels. These inhibitors restore the killing effect of L - asparaginase by blocking PKA activity.

### Experimental methods:
- **Cell lines and patient samples**: ALL cell lines with OPRM1 expression and knockdown, as well as ALL cells isolated from relapsed patients were used for the experiment.
- **Drug treatment**: Cells were treated with drugs such as L - asparaginase, H89, 14 - 22 amide.
- **Apoptosis detection**: Cell apoptosis was detected by Annexin V/PI double - staining and flow cytometry.
- **Western blot analysis**: The expression levels of BCL - 2, BAX, BAK, BAD S118 phosphorylation, caspase - 3, caspase - 9 and PARP1 were detected.
- **Subcellular fractionation**: Mitochondrial and cytoplasmic components were separated to detect the release of cytochrome C.

### Conclusions:
- This study is the first to reveal the mechanism by which L - asparaginase induces ALL cell apoptosis through the OPRM1 - mediated cAMP/PKA signaling pathway.
- It is proposed that PKA inhibitors H89 and 14 - 22 amide can be used as an effective strategy for the treatment of L - asparaginase - resistant ALL, providing new hope for the treatment of relapsed patients.